MedTrace Logo

Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT

NCT04184401 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2023-07-12

No results posted yet for this study

Summary

The aim of this study is to evaluate difference in the rate of recovery of intestinal motility according to different ascites replacement strategy after living donor liver transplantation.

Conditions

  • Living Donor Liver Transplantation

Interventions

DRUG

Ascites replacement with albumin and hartmann's solution

Combined strategy for ascites replacement * 30% of ascites: replacement with 5% albumin * 40% of ascites: replacement with Hartmann's solution

DRUG

Ascites replacement with hartmann's solution

Hartmann's solution only strategy for ascites replacement \- 70% of ascites: replacement with Hartmann's solution

Sponsors & Collaborators

  • GC Pharma

    collaborator UNKNOWN

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Ho Geol Ryu, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-11-30
Completion
2021-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04184401 on ClinicalTrials.gov